Provectus Biopharmaceuticals, Inc.
PVCT
$0.07
$0.006.82%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 223.90K | 251.30K | 75.00K | 385.90K | 390.40K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 181.40K | 243.60K | 112.20K | 147.40K | 175.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 55.10K | 73.00K | 90.80K | 34.90K | 83.40K |
| Total Current Assets | 460.40K | 567.90K | 278.00K | 568.30K | 649.50K |
|
|
|||||
| Total Current Assets | 460.40K | 567.90K | 278.00K | 568.30K | 649.50K |
| Net Property, Plant & Equipment | 117.20K | 129.60K | 141.90K | 154.10K | 16.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 577.60K | 697.50K | 419.90K | 722.40K | 666.30K |
|
|
|||||
| Total Accounts Payable | 815.30K | 716.20K | 1.18M | 1.31M | 744.00K |
| Total Accrued Expenses | 3.73M | 3.31M | 2.97M | 2.77M | 2.36M |
| Short-term Debt | 161.30K | 217.80K | 105.90K | 54.30K | 124.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.54M | 2.66M | 2.22M | 2.36M | 2.45M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 57.50K |
| Total Other Current Liabilities | -- | -- | -- | -- | 57.50K |
| Total Current Liabilities | 7.24M | 6.90M | 6.47M | 6.49M | 5.74M |
|
|
|||||
| Total Current Liabilities | 7.24M | 6.90M | 6.47M | 6.49M | 5.74M |
| Long-Term Debt | -- | 23.60K | 23.60K | -- | -- |
| Short-term Debt | 161.30K | 217.80K | 105.90K | 54.30K | 124.60K |
| Capital Leases | 66.60K | 79.20K | 91.60K | 103.90K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.31M | 7.00M | 6.59M | 6.60M | 5.74M |
|
|
|||||
| Common Stock & APIC | 257.46M | 256.60M | 255.58M | 254.55M | 253.51M |
| Retained Earnings | -264.14M | -262.85M | -261.69M | -260.38M | -258.56M |
| Treasury Stock & Other | -59.90K | -60.20K | -60.30K | -60.40K | -60.70K |
| Total Common Equity | -6.74M | -6.31M | -6.17M | -5.89M | -5.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 15.30K | 15.10K | 14.90K | 14.70K | 14.40K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 15.30K | 15.10K | 14.90K | 14.70K | 14.40K |
|
|
|||||
| Total Common Equity | -6.74M | -6.31M | -6.17M | -5.89M | -5.12M |
| Total Preferred Equity | 15.30K | 15.10K | 14.90K | 14.70K | 14.40K |
| Total Minority Interest | -6.20K | -4.00K | -16.20K | -3.80K | 33.80K |
| Total Equity | -6.73M | -6.30M | -6.17M | -5.87M | -5.07M |
|
|
|||||